“Uncovering the Truth: Bronstein, Gewirtz & Grossman LLC Investigates Atara Biotherapeutics for Potential Wrongdoings in the Business and Professional Services Industry”
Investigation on Atara Biotherapeutics, Inc. New York City, NY / ACCESS Newswire / February 2, 2025 Bronstein, Gewirtz & Grossman, LLC is currently conducting an investigation regarding potential claims on behalf of purchasers of Atara Biotherapeutics, Inc. (“Atara” or “the Company”) (NASDAQ: ATRA). If you are an investor who bought Atara securities, we urge you…